BD, B. Braun Melsungen AG, and Thermo Fisher Scientific Inc. are expected to Dominate the Europe Needles Market in 2021

Europe Needles Market is expected to grow with the CAGR of 7.2% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @

Europe needles market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Europe needles market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In April 2021, B. Braun Melsungen AG has announced that they received If DESIGN AWARD 2021 for their latest Health/Medical category products which won over 98 member jury. This Award was organized and sponsored by IF International Forum Design GmbH. This enhanced the company’s profile and reputation thereby attracting more customers and increased profit for market.

BD is the dominating player in Europe needles market. The other key players existing in the market are B. Braun Melsungen AG, Novo Nordisk A/S, YPSOMED, Owen Mumford Limited, HTL-STREFA S.A., Thermo Fisher Scientific Inc., Smiths Medical, Boston Scientific Corporation, Hamilton Company, CONMED Corporation, Johnson & Johnson Services, Inc., Medtronic, Terumo Corporation, Allison Medical, Inc., Smith+Nephew, Retractable Technologies, Inc., ARGON MEDICAL., STERYLAB S.r.l., ZAMAR CARE., BPB medica – Biopsybell and among others.

Europe Needles MarketBD

BD was founded in the year 1897 and is headquartered in New Jersey, U.S. The company is engaged in the development, manufacturing and sale of wide range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates its business via two business segments including medical, life sciences and interventional in which medical is the market focused segment. The company has many product categories including anesthesia delivery, biopsy, biosciences, biosurgery: sealant and hemostat solutions, cervical cancer screening, diabetes care, drug delivery systems, drainage, gastrointestinal care, hazardous drug safety, hernia repair and fixation, home care, infection therapy, interventional specialties, lab automation, microbiology solutions, molecular diagnostics, prostate health, syringes and needles and among others in which syringes and needles is market focused category.

  • In December 2017, BD announced in their website that company made strategic acquisition with C. R. Bard, Inc. for USD 16 Billion was done to improve both company’s treatment process for diseases to get better patient outcomes, thereby anticipated in improving company’s overall presence and income.

The company has presence across North America, South America, Europe, Asia-Pacific, and Middle East and Africa. The company also has various subsidiaries including Accuri Cytometers, Inc (Delaware), Accuri Cytometers (Europe), Ltd. (U.K.), Atto Bioscience, Inc. (Delaware), and B-D (U.K.) Ltd. (U.K.) among others.

B. Braun Melsungen AG  

B. Braun Melsungen AG is headquartered in Melsungen, Germany and was founded in 1839. The company is focused on providing the effective treatments along with the user friendly products and product systems that are cost effective and will provide the opportunities for the market. The company has several product categories including abdominal surgery, diabetes care, infusion, nutrition therapy, ostomy care, wound management, cardio-thoracic surgery, interventional vascular therapy, orthopedic surgery, spine surgery, continence care & urology, extracorporeal blood treatment, sterile goods management, neurosurgery, infection prevention,  IV drugs, regional anesthesia, other products, wound management, wound closure in which infusion is the market focused category.

For instance,

  • In June 2020, B. Braun Melsungen AG announced that their subsidiary Aesculap won five consecutive awards at Red Dot Design Award 2020. The three latest product of their company including Container system, OrthoPilot, Multitool received five awards at the session. This improved company’s profile and global position gaining more attention from worldwide customers.

The company has wide presence across Africa, Asia-Pacific, Europe, South America, and North America. The company also has various subsidiary companies including Aesculap (Germany), Aesculap AG (Germany), B. Braun Avitum UK Ltd (United Kingdom), B. Braun GmbH (Germany), and B. Braun of America, Inc. (America) among others.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. was founded in the year 2006 and is headquartered in Massachusetts, U.S. The company is focused on making the world healthier, cleaner and safer by accelerating life science research, solving complex analytical challenges and improving patient’s therapies and diagnostics. The company operates in three business segments including life science solutions, analytical instruments, specialty diagnostics, laboratory products and services in which life science solutions is the focused segment. The company has many product categories which are thermo scientific, applied biosystems, Invitrogen, fisher scientific, unity lab services, patheon in which thermo scientific is the focused category.

  • In February 2021, Thermo Fisher Scientific announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by Life Science Leader and Outsourced Pharma, recognize top contract manufacturing partners as evaluated by biopharma and biotech companies. It is estimated that this recognition anticipated to strengthen company’s footprints in global market and leading to Upsurge Company’s growth in the coming years

The company has presence across The Americas, Europe, Middle East and Africa, and Asia-Pacific. The company also has various subsidiaries including Thermo Electron North America LLC (U.S.), Fisher Scientific GmbH (Germany), Fisher Scientific Korea Ltd (Korea), Thermo Fisher Scientific Germany BV & Co KG (Germany), and Thermo Fisher Scientific K.K. (Japan) among others.